We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current ZOM market cap is 279.29M. The company's latest EPS is USD -0.0352 and P/E is -7.95.
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 4.13M | 18.93M | 25.19M |
| Operating Income | -18.14M | -14.16M | -21.37M | -21.92M | -31.59M |
| Net Income | -19.78M | -16.91M | -18.38M | -17.02M | -34.53M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 4.18M | 66.14M | 280.4M | 279.61M | 253.2M |
| Total Liabilities | 2.09M | 15.08M | 9.51M | 12.22M | 13.18M |
| Total Equity | 2.1M | 51.07M | 270.89M | 267.39M | 240.02M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -15.63M | -16.24M | -14.28M | -11.67M | -15.98M |
| Investing | -687k | 1.01M | -71.93M | -155.88M | 1.58M |
| Financing | 14.89M | 76.72M | 219.16M | 8k | N/A |
| Market Cap | 279.29M |
| Price to Earnings Ratio | -7.95 |
| Price to Sales Ratio | 10.89 |
| Price to Cash Ratio | 21.21 |
| Price to Book Ratio | 1.14 |
| Dividend Yield | - |
| Shares Outstanding | 979.95M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 0.34 (75.56%) |
| Company Name | Zomedica Pharmaceuticals Corp |
| Address |
100 phoenix drive, suite 125 ann arbor, michigan 48108 |
| Website | https://www.zomedica.com |
| Industry | unit inv tr, closed-end mgmt (6726) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
